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  Background  At least 75% of head and neck cancers are attributable to a combination of cigarette smoking and alcohol 
drinking. A precise understanding of the independent association of each of these factors in the absence 
of the other with the risk of head and neck cancer is needed to elucidate mechanisms of head and neck 
carcinogenesis and to assess the efficacy of interventions aimed at controlling either risk factor. 
  Methods  We examined the extent to which head and neck cancer is associated with cigarette smoking among never 
drinkers and with alcohol drinking among never users of tobacco. We pooled individual-level data from 15 
case – control studies that included 10  244 head and neck cancer case subjects and 15  227 control subjects, 
of whom 1072 case subjects and 5775 control subjects were never users of tobacco and 1598 case subjects 
and 4051 control subjects were never drinkers of alcohol. Odds ratios (ORs) and 95% confidence intervals 
(CIs) were estimated using unconditional logistic regression models. All statistical tests were two-sided. 
  Results  Among never drinkers, cigarette smoking was associated with an increased risk of head and neck cancer (OR 
for ever versus never smoking = 2.13, 95% CI = 1.52 to 2.98), and there were clear dose – response relation-
ships for the frequency, duration, and number of pack-years of cigarette smoking. Approximately 24% (95% 
CI = 16% to 31%) of head and neck cancer cases among nondrinkers in this study would have been pre-
vented if these individuals had not smoked cigarettes. Among never users of tobacco, alcohol consumption 
was associated with an increased risk of head and neck cancer only when alcohol was consumed at high fre-
quency (OR for three or more drinks per day versus never drinking = 2.04, 95% CI = 1.29 to 3.21). The associ-
ation with high-frequency alcohol intake was limited to cancers of the oropharynx/hypopharynx and larynx. 
  Conclusions  Our results represent the most precise estimates available of the independent association of each of the 
two main risk factors of head and neck cancer, and they exemplify the strengths of large-scale consortia 
in cancer epidemiology. 
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 Head and neck cancers are a group of related neoplasms that arise 
in the oral cavity, pharynx, and larynx. Almost 600  000 new cases 
of head and neck cancer and 300  000 deaths occur worldwide 
each year (1). At least 75% of head and neck cancers diagnosed 
in Europe, the United States, and other industrialized regions are 
attributable to the combination of cigarette smoking and alcohol 
drinking (2,3). However, the respective contributions of these 
risk factors to head and neck cancer risk are difﬁ cult to study be -
cause these two habits are strongly associated with each other (4,5). 
A precise understanding of the independent associations between 
cigarette smoking and alcohol drinking and the risk of head and 
neck cancer has important implications for elucidating the mecha-
nisms of head and neck carcinogenesis and for assessing the ef -
fects of interventions to modify these risk factors. 
 The etiologic factors for head and neck cancer in individuals 
who have never used tobacco products are not yet well understood. 
Of the head and neck cancer patients, 5% – 30% are never smokers 
(6 – 19). Head and neck tumors in never smokers are thought to be 
distinct from those in smokers because they have fewer TP53 gene 
mutations, a lower frequency of loss of heterozygosity on chromo-
some arms 3p and 4q and at chromosome 11q13 (chromosomal 
sites at which loss of heterozygosity occurs during the progression 
of oral cancer), and fewer microsatellite alterations than head and 
neck tumors that arise in smokers (20). Analyses of never users of 
tobacco are necessary to establish the etiologic role of risk factors 
other than tobacco use because tobacco use is the primary risk fac-
tor for head and neck cancer (21), and thus, residual confounding 
by tobacco use is difﬁ cult to rule out. Similarly, because alcohol 
drinking is a risk factor for head and neck cancer (22), analyses of 
nondrinkers are needed to rule out confounding by alcohol 
when estimating the effect of cigarette smoking. A pooled analysis 
within a consortium is a cost-effective method for generating a 
large sample size for the analysis of rare subgroups such as head 
and neck cancer patients who are never users of tobacco and never 
drinkers. 
 Previous estimates of the independent associations among 
cigarette smoking, alcohol drinking, and the risk of head and neck 
cancer (23 – 28) were imprecise because of the small numbers of 
case subjects who were never drinkers or never tobacco smokers 
(typically fewer than 100). To overcome this limitation, we con-
ducted a pooled analysis of cigarette smoking among never 
drinkers and alcohol drinking among never users of tobacco. This 
analysis was made possible by the establishment, in 2004, of the 
International Head and Neck Cancer Epidemiology (INHANCE) 
consortium as an international collaboration among research 
groups that were conducting large, ongoing (or recently com-
pleted) molecular epidemiology studies of head and neck cancer. 
The primary goal of the consortium is to address research 
questions — such as the independent associations among cigarette 
smoking, alcohol drinking, and head and neck cancer — that are 
difﬁ cult to answer in individual studies, which typically include 
500 – 1000 case subjects and a comparable number of control sub-
jects. Our goal was to examine whether cigarette smoking and 
alcohol drinking are each a risk factor in the absence of the other 
and to explore whether risk estimates differ by cancer site within 
the head and neck. 
 Methods 
 Studies 
 Investigators who had recently conducted molecular epidemiologic 
studies of head and neck cancers were invited to participate in the 
INHANCE consortium. The included studies had to have a proto-
col for the recruitment of case and control subjects and to have 
used a structured epidemiologic questionnaire that addressed both 
tobacco and alcohol use. We also invited investigators who had 
conducted high-quality, large-scale epidemiologic studies that 
lacked a molecular component to participate in the INHANCE 
consortium. The eligibility criteria for these studies were that they 
include more than 300 head and neck cancer case subjects and that 
information be available on demographic and tumor characteristics, 
alcohol consumption, and tobacco use habits (i.e., cigarettes, cigars, 
pipes, and, where relevant, snuff and chewing tobacco). 
 We initially pooled the data from 15 individual case – control 
studies (6 – 19) that included 10  302 head and neck cancer case 
subjects and 15  329 control subjects (data version 1.0). Case and 
control subjects with missing data on age, sex, or race/ethnicity 
and case subjects with missing information on the site of origin 
of their cancer (58 case subjects and 102 control subjects) were 
 CONTEXT AND CAVEATS 
 Prior knowledge 
 Although at least 75% of head and neck cancers diagnosed in 
industrialized regions are attributable to the combination of ciga-
rette smoking and alcohol drinking, the respective contributions of 
these risk factors to head and neck cancer risk are unclear because 
the two habits are strongly associated with each other. 
 Study design 
 A pooled analysis of data from 15 case – control studies of head and 
neck cancer risk and cigarette smoking among never drinkers and 
head and neck cancer risk and alcohol drinking among never users 
of tobacco. 
 Contribution 
 Among never drinkers, cigarette smoking was associated with an 
increased risk of head and neck cancer, and there were clear dose –
 response relationships for the frequency, duration, and number of 
pack-years of cigarette smoking. Among never users of tobacco, 
high-frequency alcohol consumption was associated with increased 
risks of cancers of the oropharynx/hypopharynx and larynx only. 
 Implications 
 Approximately one quarter of the head and neck cancers among 
the never drinkers were attributable to ever cigarette smoking, 
assuming a causal relationship. Only 7% of the head and neck can-
cers were attributable to alcohol drinking among the never users 
of tobacco, assuming a causal relationship. 
 Limitations 
 Misclassification of alcohol exposure, particularly exposure to hard 
liquors, and recall bias could have influenced the observed associa-
tions. Regional differences in social acceptance of tobacco habits 
and alcohol consumption may have influenced how a subject 
responded to questions about these practices in a face-to-face 
interview. 
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excluded from this analysis. Thus, the data for this analysis in -
cluded 10  244 head and neck cancer case subjects and 15  227 con-
trol subjects. 
 The characteristics of the individual studies included in the 
pooled data are shown in  Table 1 . The studies are referred to by 
location and by whether they are multicenter in study design. Most 
were hospital-based case – control studies, and in most studies, the 
control subjects were frequency matched to the case subjects on 
age, sex, and additional factors (e.g., study center, hospital, and 
race/ethnicity). The Los Angeles study individually matched the 
control subjects to case subjects on age decade, sex, and neighbor-
hood, although in the study analysis the matching was broken. 
Face-to-face interviews were conducted in all studies except for the 
Iowa study, in which subjects completed self-administered ques-
tionnaires. Written informed consent was obtained from all study 
subjects, and the investigations were approved by the institutional 
review board at each study center. Blank questionnaires were col-
lected from all the individual studies to assess the comparability 
of the collected data and of the wording of interview questions 
among the studies. Data from individual studies were received at 
the International Agency for Research on Cancer (IARC) with 
personal identiﬁ ers removed. Each data item was checked for 
illogical or missing values. Queries were sent to the investigators 
to resolve inconsistencies. 
 Case subjects were included in this analysis if their tumor had 
been classiﬁ ed by the original study as an invasive tumor of the 
oral cavity, oropharynx, hypopharynx, oral cavity or pharynx not 
otherwise speciﬁ ed, or larynx or head and neck cancer unspeciﬁ ed 
according to the International Classiﬁ cation of Diseases for 
Oncology, Version 2 [ICD-O-2; (29)] or the International 
Classiﬁ cation of Diseases, 9th [ICD-9; (30)] or 10th [ICD-10; (31)] 
Revision. Subjects with salivary gland cancers (ICD-O-2 codes 
C07 – C08) were excluded from our analysis because the etiologic 
pattern of these cancers differs from that of head and neck can-
cers (32). For studies that used ICD-O-2 or ICD-10 classiﬁ cation 
(Central Europe, Iowa, Los Angeles, Seattle, Puerto Rico, and 
South America studies), tumors were assigned to one of the six 
categories as follows: 1) oral cavity (includes lip, tongue, gum, ﬂ oor 
of mouth, and hard palate): codes C00.3 – C00.9, C02.0 – C02.3, 
C03.0, C03.1, C03.9, C04.0, C04.1, C04.8, C04.9, C05.0, C06.0 –
 C06.2, C06.8, and C06.9; 2) oropharynx (includes base of tongue, 
lingual tonsil, soft palate, uvula, tonsil, and oropharynx): codes 
C01.9, C02.4, C05.1, C05.2, C09.0, C09.1, C09.8, C09.9, C10.0 –
 C10.4, C10.8, and C10.9; 3) hypopharynx (includes pyriform 
sinus and hypopharynx): codes C12.9, C13.0 – C13.2, C13.8, and 
C13.9; 4) oral cavity, pharynx unspeciﬁ ed or overlapping: codes 
C02.8, C02.9, C05.8, C05.9, C14.0, C14.2, and C14.8; 5) larynx 
(includes glottis, supraglottis, and subglottis): codes C32.0 – C32.3 
and C32.8 – C32.9; and 6) head and neck cancer unspeciﬁ ed: 
deﬁ ned as overlapping lesions when more than one ICD topo-
graphic code was available for each case subject and the multiple 
sites were not within one of the categories listed above. 
 For studies that classiﬁ ed tumor site data according to ICD-9 
codes (Milan, Aviano, France, Italy Multicenter, Switzerland, 
North Carolina, Tampa, and International Multicenter studies), 
the assigned codes were converted to ICD-O-2 codes. For the 
Houston study, instead of the original ICD code, we received the 
study surgeon’s classiﬁ cation of subsites as oral cavity, oropharynx, 
hypopharynx, or larynx, consistent with the ICD-O-2 group 
designations listed above. There were 2854 case subjects with 
oral cavity cancer, 3358 with pharyngeal cancer (oropharyngeal or 
hypopharyngeal), 905 with oral cavity/pharynx not otherwise 
speciﬁ ed, 2821 with laryngeal cancer, and 306 with unspeciﬁ ed 
head and neck cancer. 
 Some studies (i.e., the France, North Carolina, Tampa, and 
Houston studies) restricted eligibility to case subjects with squa-
mous cell carcinomas (SCC). For other studies that provided the 
ICD-O-2 histologic coding for each tumor (i.e., the Switzerland, 
Central Europe, Seattle, Los Angeles, Puerto Rico, and South 
America studies and the following centers in the International 
Multicenter study: Australia, Aviano, Barcelona, Canada, Cuba, 
Granada, Ireland, Milan, Poland, Sevilla, and Udine), we used the 
following codes to identify case subjects with SCC: 8070/3, 
8071/3, 8072/3, 8073/3, 8074/3, 8075/3, 8076/3, 8078/3, 8083/3, 
and 8084/3. The Iowa study provided a variable instead of ICD 
coding to specify which case subjects had SCC. For the Milan and 
Aviano studies, the Italy Multicenter study, and four centers in 
the International Multicenter study (i.e., Bangalore, Madras, and 
Trivandrum in India and Khartoum in Sudan), no data were avail-
able on histologic type. Of the 7613 head and neck cancer case 
subjects for whom histologic information was available, 7025 
(92.3%) had SCC. 
 The questions about tobacco and alcohol use on study ques-
tionnaires were conceptually similar across studies, although the 
exact wording differed. The questions about tobacco and alcohol 
use were examined carefully for comparability before variables 
were created for this report. Each study subject was asked whether 
he or she had ever been a smoker of cigarettes, cigars, or pipes. 
However, the deﬁ nitions of ever smoking varied widely among the 
individual studies (i.e., for cigarettes, ever smoking was deﬁ ned as 
smoked  ≥ 100 cigarettes in a lifetime [Central Europe, Los Angeles, 
North Carolina, Puerto Rico, Seattle, and Houston studies], as 
smoked one or more cigarettes per day for  ≥ 1 year [International 
Multicenter, Tampa, South America, Milan, Aviano, Italy 
Multicenter, and Switzerland studies], as smoked one-half pack or 
more per week for  ≥ 1 year [Iowa study], and as smoked “regularly” 
[France study]; for cigars and pipes, ever smoking was deﬁ ned as 
smoked cigars or pipes for  ≥ 6 months [Seattle, North Carolina, 
and Puerto Rico studies], as smoked one or more cigars or one or 
more pipefuls of tobacco per month for  ≥ 6 months [Los Angeles 
study], as smoked one or more cigars or pipes per day for  ≥ 1 year 
[Milan, Aviano, Italy, Switzerland, South America], as smoked 
cigars or pipes “regularly” [France and Central Europe studies], as 
ever used cigars or pipes [Houston study], as smoked at least one 
cigar or one pipeful of tobacco a week for  ≥ 1 year [Iowa], as 
smoked daily for >1 year [International Multicenter study], and as 
smoked a cigar or pipe once a day for  ≥ 1 year [Tampa study]. 
Variables on the frequency (i.e., number of cigarettes, cigars, or 
pipes smoked per day), duration (in years), and pack-years (i.e., 
cumulative smoking) of tobacco smoking were available in all stud-
ies. For several studies (i.e., the Central Europe, South America, 
France, and North Carolina studies), the frequency and duration 
variables were calculated centrally; for all other studies, we used 
the data calculated by the individual studies. 
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 Information about snuff use and chewing habits was collected 
by the Puerto Rico study, the International Multicenter studies, 
and all studies in North America. Snuff use and chewing are not 
common behaviors in Europe or South America, except in speciﬁ c 
populations (e.g., Norway and Sweden) that were not included 
in the pooled dataset. For the Indian study population in the 
International Multicenter study, information on betel quid and 
areca nut chewing was collected. The deﬁ nitions of ever chewing 
and ever use of snuff differed across studies (i.e., as ever use of snuff 
or chew for  ≥ 6 months [Seattle, North Carolina, and Puerto Rico 
studies], as use of at least one small can of snuff or one pouch of 
chewing tobacco per week for  ≥ 1 year [Iowa study], as use of chew 
or snuff at least once per day for  ≥ 1 year [Tampa study], as daily 
chewing of tobacco, betel quid, areca nut, or pan masala or daily 
snufﬁ ng of tobacco for  ≥ 1 year [International Multicenter studies], 
as at least one plug of tobacco or one pinch of snuff of tobacco per 
month for  ≥ 6 months [Los Angeles study], and as ever use of snuff 
or dip or chewing tobacco [Houston study]). Frequency and dura-
tion variables for chewing and snuff use habits were pooled across 
relevant studies. For this study, never users of tobacco were deﬁ ned 
as individuals who had not used cigarettes, cigars, pipes, snuff, or 
chewing products during their lifetimes. 
 In the alcohol section of the study questionnaires, subjects 
were asked if they were alcohol drinkers; for those who responded 
that they were, subsequent questions were asked about the fre-
quency of drinking, the duration of drinking, and the different 
types of alcoholic beverages consumed (i.e., beer, wine, hard 
liquors, and/or aperitifs). The deﬁ nitions of ever alcohol drinking 
were “ever” consumed alcohol (France, Central Europe, Aviano, 
Milan, Italy Multicenter, and Switzerland studies); consumed 
more than four drinks in a year (Seattle study); consumed one or 
more drinks per month for 6 or more months in a lifetime (Los 
Angeles study); consumed 12 or more drinks of any kind of alcohol 
in a lifetime (Puerto Rico study); consumed alcoholic beverages 
one or more times per month (International Multicenter and 
South America studies); consumed an average of one or more 
drinks per week for 1 or more years (Iowa study); consumed alco-
hol one or more times per week for 1 or more years (Tampa and 
Houston studies); and consumed beer, wine, or liquor four or more 
times per month (North Carolina study). 
 The volume speciﬁ cation for alcoholic beverages by type dif-
fered across studies. For example, a glass of wine was deﬁ ned as 
100 – 150 mL in the European studies, whereas the North American 
studies deﬁ ned a wine glass as 3.6 – 5 ounces. To estimate cumula-
tive alcohol consumption (milliliters of beverage over a lifetime) 
for each beverage type, we converted into milliliters the beverage 
volume speciﬁ ed in the questionnaire for the alcoholic beverage 
type and multiplied this value by the number of that beverage type 
consumed per week and the duration of beverage type consump-
tion reported. We then multiplied the volume percentage of pure 
ethanol by beverage type (i.e., 5% for beer, 12% for wine, 40% for 
liquor, and 40% for aperitifs) to the beverage volume (33) to esti-
mate the cumulative consumption of pure ethanol for each subject 
in milliliters. We then divided the cumulative consumption of pure 
ethanol by 15.6 mL, the mean volume of pure ethanol per drink 
across all alcoholic beverage types for the 15 studies, to calculate 
the lifetime number of standardized drinks consumed by each 
subject (i.e., one standardized drink contains 15.6 mL of pure 
ethanol). Cumulative alcohol consumption was then expressed in 
drink-years. To obtain the frequency of consumption of each alco-
holic beverage type, the cumulative consumption for each type of 
alcoholic beverage was divided by the corresponding duration. 
For the overall frequency of alcohol drinking (i.e., the number of 
drinks per day), the frequency of consumption of each alcoholic 
beverage type was weighted by the corresponding duration. For 
the France, Iowa, and Tampa studies, data on duration by type of 
alcoholic beverage were not available; thus, the average of the 
frequency of all alcoholic beverage types within those studies was 
used as the overall frequency. 
 Data on passive smoking exposure at home and at work (never/
ever), which were available in six studies (Central Europe, Tampa, 
Los Angeles, Houston, Puerto Rico, and South America studies), 
were pooled. A variable representing the number of ﬁ rst-degree 
relatives who had head and neck cancer was also pooled across 
the 12 studies that had assessed this information (Milan, Aviano, 
Italy Multicenter, Switzerland, Central Europe, North Carolina, 
Tampa, Los Angeles, Houston, Puerto Rico, South America, and 
International Multicenter studies). 
 Statistical Methods 
 The associations between head and neck cancer and cigarette 
smoking by drinking status and between head and neck cancer and 
alcohol drinking by tobacco use status were assessed by estimating 
odds ratios (ORs) and 95% confidence intervals (CIs) using uncon-
ditional logistic regression models for each case – control study. The 
models included age (<40, 40 – 44, 45 – 49, 50 – 54, 55 – 59, 60 – 64, 65 –
 69, 70 – 74, or  ≥ 75 years), sex, education level (no formal education, 
less than junior high school, some high school, high-school gradu-
ate, vocational/some college, or college graduate/postgraduate), 
race/ethnicity (non-Hispanic white, black, Hispanic/Latino, Asian/
Pacific Islander, Latin American, other), and study center. To 
calculate summary estimates of associations, the study-specific esti-
mates were included in a two-stage random-effects logistic regres-
sion model that included the DerSimonian and Laird (34) estimator, 
which allows for unexplained sources of heterogeneity among 
studies. Pooled odds ratios were also estimated with a fixed-effects 
logistic regression model that adjusted for age, sex, education level, 
race/ethnicity, and study center. In addition, we adjusted for years 
of cigar smoking (as a continuous variable) and years of pipe 
smoking (as a continuous variable) when assessing cigarette smok-
ing among never drinkers. We estimated odds ratios for cigarette 
smoking for both drinkers and nondrinkers in the same model 
for each study and odds ratios for alcohol drinking among tobacco 
users and never users of tobacco so that all the data could be used 
to estimate confounder relationships. 
 For subjects with a missing education level (17 case subjects and 
80 control subjects among never users of tobacco, 56 case subjects 
and 108 control subjects among the never drinkers), we applied 
multiple imputation with the PROC MI procedure in SAS statisti-
cal software (version 9.1; SAS Institute Inc, Cary, NC) so that 
these subjects could be included in the analyses. We assumed that 
the education data were missing at random, i.e., whether or not 
education level was missing did not depend on any other unob-
served or missing values (35). We used a logistic regression model 
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(36) to predict education level for each of the geographic regions 
separately using age, sex, race/ethnicity, study center, and case –
 control status as the covariates. The logistic regression results to 
assess summary estimates for cigarettes and alcohol drinking 
for the ﬁ ve imputations were combined by using the PROC 
MIANALYZE procedure in SAS statistical software. 
 We tested for heterogeneity among the study odds ratios by 
conducting a likelihood ratio test comparing a model that included 
the product terms between each study (other than the reference 
study) with the variable of interest and a model without a product 
terms (degrees of freedom = number of studies  − 1), for the risk of 
head and neck cancer combined and for the risk of each of the 
head and neck cancer subsites. We report the random-effects 
estimates for situations in which heterogeneity was detected 
consistently for assessments of the risk of head and neck cancers 
associated with cigarette smoking among never drinkers or with 
alcohol drinking among never users of tobacco. Fixed-effects 
estimates are reported for all other models. We examined whether 
the results from the two-stage random-effects model and from the 
ﬁ xed-effects logistic regression model were comparable to each 
other in terms of the magnitude of the effect. We also conducted 
an inﬂ uence analysis, in which each study was excluded one at a 
time to ensure that the statistical signiﬁ cance and magnitude of 
the overall summary estimate were not dependent on any one 
study. 
 Analyses were stratiﬁ ed by cancer site (oral cavity, pharynx, oral 
cavity/pharynx not speciﬁ ed, and larynx), age category ( ≤ 45, 46 –
 50, 51 – 60, 61 – 70, and >70 years), sex, race/ethnicity, education 
level, source of control subjects (hospital based versus population 
based), and geographic region (Europe, North America, South/
Central America, others). We also repeated the analysis restricting 
the cases to SCC histology within the set of studies that had 
collected histology information. All statistical tests were two-
 sided, and  P value less than .05 was considered to be statistically 
signiﬁ cant. 
 The attributable fraction (AF) for cigarette smoking among 
never drinkers and for alcohol drinking among never users of 
tobacco was estimated using the formula AF = p(ec) × (OR  − 1)/OR, 
where p(ec) is the proportion exposed among the case subjects (4). 
 Results 
 Characteristics of Studies and Subjects 
 Approximately 15.6% of the case subjects and 26.6% of the control 
subjects in data version 1.0 were never drinkers and 10.5% of the 
case subjects and 37.9% of the control subjects were never users of 
tobacco ( Table 1 ). The International Multicenter study contributed 
39.9% of the case subjects and 21.0% of the control subjects who 
were never drinkers; the majority of these subjects (406 case sub-
jects and 487 control subjects) were from India, where the preva-
lence of alcohol drinking is low. The International Multicenter and 
Houston studies contributed the largest proportions of case sub-
jects who were never users of tobacco (19.4% and 17.4%, respec-
tively). Characteristics of case and control subjects who were never 
drinkers or never users of tobacco are shown in  Table 2 . The case 
and control subjects among the never drinkers and among the never 
users of tobacco differed with respect to distributions of age, sex, 
race/ethnicity, and education level. The never drinkers were more 
likely to be younger than 40 years or 75 years or older, female, 
and Asian/Pacific Islanders and had less education than the overall 
group of case subjects. The never users of tobacco were more likely 
to be younger than 40 years or 75 years or older and female and 
had completed a higher level of education than the overall group of 
case subjects. 
 Cigarette Smoking and Head and Neck Cancer Risk 
Among Never Drinkers 
 Cigarette smoking was associated with an increased risk of head 
and neck cancer among never drinkers, and there were clear dose –
 response relationships for smoking frequency, duration, and cumu-
lative consumption ( Table 3 ).  Figure 1 shows a forest plot of the 
study-specific risk estimates for ever versus never cigarette smoking 
among never drinkers and the combined risk estimate (OR for ever 
versus never cigarette smoking = 2.13, 95% CI = 1.52 to 2.98). 
Seven studies (i.e., the Milan, Italy Multicenter, Switzerland, North 
Carolina, Houston, South America, and International Multicenter 
studies) reported a positive association between ever cigarette 
smoking and the risk of head and neck cancer in never drinkers. 
The Milan, Seattle, Iowa, and South America studies contributed 
the most to heterogeneity among the odds ratios (i.e., excluding 
them increased the  P value for heterogeneity from <.001 to .208). 
When these four studies were not included in the summary esti-
mate, the observed association (OR = 2.02, 95% CI = 1.61 to 2.53) 
was consistent with the results from the full analysis. The results 
also did not change substantially when we restricted the analysis to 
large-scale studies (i.e., those with more than 500 case subjects in 
the individual study). Because a large proportion of the never drink-
ers were from India, we also estimated the odds ratio after exclud-
ing this group of subjects and found that doing so did not change 
the odds ratio substantially (OR = 2.21, 95% CI = 1.54 to 3.18). 
The influence analysis showed that no one study was responsible 
for either the magnitude or the statistical significance of the sum-
mary estimate. 
 We next examined risks associated with speciﬁ c head and neck 
cancer subsites. The risk of laryngeal cancer was strongly associ-
ated with cigarette smoking among never drinkers, whereas the 
risk of oral cavity and pharyngeal cancers was not as strong ( Table 
4 ). These differences and magnitudes of the risk estimates were not 
affected by excluding individuals who smoked cigars or pipes or 
who had chewing or snuff use habits. Exclusion of the subjects 
from India also did not change the heterogeneity in associations 
by cancer subsite. No strong differences among the strata were 
observed in the analysis of cigarette smoking among never drinkers 
stratiﬁ ed by age, race, ethnicity, education level, or study design 
(data not shown). 
 The association between ever smoking and the risk of head 
and neck cancer among never drinkers was slightly stronger for 
women (OR = 2.33, 95% CI = 1.56 to 3.49) than for men (OR = 
1.65, 95% CI = 1.14 to 2.39), but this difference was not statisti-
cally signiﬁ cant; this sex difference was not apparent for associa-
tions with smoking frequency and duration categories (data not 
shown). Cigarette smoking was associated with greater risks of 
head and neck cancer among never drinkers for studies in Europe 
(OR for ever versus never smoking = 3.45, 95% CI = 1.90 to 5.89) 
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 Table 2.  Selected characteristics of head and neck cancer case subjects and control subjects who were never users of tobacco 
or never drinkers 
 Never drinkers * Never users of tobacco † 
 
Case subjects 
(N = 1598)
Control subjects 
(N = 4051)
Case subjects 
(N = 1072)
Control subjects 
(N = 5775) 
 Characteristic n % n % n % n % 
 Age, y  
  <40 120 7.5 339 8.4 128 11.9 499 8.6 
  40 – 44 90 5.6 344 8.5 79 7.4 463 8.0 
  45 – 49 144 9.0 449 11.1 117 10.9 663 11.5 
  50 – 54 215 13.5 608 15.0 134 12.5 896 15.5 
  55 – 59 248 15.5 638 15.7 149 13.9 960 16.6 
  60 – 64 216 13.5 580 14.3 126 11.8 841 14.6 
  65 – 69 190 11.9 493 12.2 98 9.1 698 12.1 
  70 – 74 183 11.5 349 8.6 116 10.8 481 8.3 
  ≥ 75 192 12.0 251 6.2 125 11.7 274 4.7 
 P ‡ <.001 <.001 
 Sex  
  Female 910 56.9 2117 52.3 531 49.5 2735 47.4 
  Male 688 43.1 1934 47.7 541 50.5 3040 52.6 
 P ‡ .002 .191 
 Race/ethnicity §  
  Non-Hispanic white 795 49.7 2586 63.8 763 71.2 4397 76.1 
  Black 111 6.9 233 5.8 62 5.8 238 4.1 
  Hispanic/Latino 40 2.5 152 3.8 45 4.2 170 2.9 
  Asian/Pacific Islander 421 26.3 530 13.1 70 6.5 393 6.8 
  Other 16 1.0 55 1.4 9 0.8 71 1.2 
  Latin American 215 13.5 495 12.2 123 11.5 506 8.8 
 P ‡ <.001 .001 
 Education level ||  
  No formal education 319 20.0 205 5.1 62 5.8 156 2.7 
  Less than junior high 
   school
520 32.5 1262 31.2 321 29.9 2317 40.1 
  Some high school 154 9.6 534 13.2 108 10.1 650 11.3 
  High-school graduate 197 12.3 653 16.1 150 14.0 641 11.1 
  Vocational school, some 
   college
183 11.5 633 15.6 171 16.0 889 15.4 
  College graduate/
   postgraduate
169 10.6 656 16.2 243 22.7 1042 18.0 
  Missing 56 3.5 108 2.7 17 1.6 80 1.4 
 P ‡ <.001 <.001 
 *  The definitions of ever alcohol drinking were 1) ever consumed alcohol (France, Central Europe, Aviano, Milan, Italy Multicenter, and Switzerland studies), 2) more 
than four drinks in a year (Seattle study), 3) one or more drinks per month for 6 or more months in a lifetime (Los Angeles study), 4) 12 or more drinks of any kind 
of alcohol in a lifetime (Puerto Rico study), 5) one or more times per month (Multicenter, South America studies), 6) average of one or more drinks per week for 1 
or more years (Iowa study), 7) one or more times per week for 1 or more years (Tampa and Houston studies), and 8) four or more times per month of beer, wine, 
or liquor (North Carolina study). 
 †  The definitions of ever cigarette smoking were 1) smoked 100 or more cigarettes in a lifetime (Central Europe, Los Angeles, North Carolina, Puerto Rico, Seattle, 
and Houston studies), 2) smoked one cigarette/day for 1 or more years (International Multicenter, Tampa, South America, Milan, Aviano, Italy Multicenter, and 
Switzerland studies), 3) smoked one-half pack per week for 1 or more years (Iowa study), and 4) smoked ”regularly” (France study). The definitions of ever 
cigar and pipe smoking were smoked cigars or pipes for 6 or more months (Seattle, North Carolina, and Puerto Rico studies), smoked one cigar or one pipeful 
of tobacco per month for 6 or more months (Los Angeles study), smoked one cigar or pipe/day for 1 or more years (Milan, Aviano, Italy, Switzerland, and South 
America studies), smoked cigars or pipes “regularly” (France and Central Europe studies), ever used cigars or pipes (Houston study), one cigar or one pipeful of 
tobacco a week for 1 or more years (Iowa), smoked daily for 1 or more years (International Multicenter study), and smoked a cigar or pipe once a day for 1 or 
more years (Tampa study). The definitions of ever chewing and ever use of snuff differed across studies (i.e., ever use of snuff or chew for  ≥ 6 months [Seattle, 
North Carolina, and Puerto Rico studies], one small can of snuff or one pouch of chewing tobacco per week for  ≥ 1 year [Iowa study], use chew or snuff once per 
day for  ≥ 1 year [Tampa study], chewed daily tobacco, betel quid, areca nut, or pan masala or snuffed tobacco daily for  ≥ 1 year [International Multicenter studies], 
one plug of tobacco or one pinch of snuff of tobacco per month for  ≥ 6 months [Los Angeles study], and ever use of snuff or chew [Houston study]). 
 ‡  Chi-square test (two-sided). 
 §  Information on ethnicity was not collected in the Central Europe and South America studies. In the Central Europe study, all subjects were classified as non-Hispanic 
white because the large majority of these populations were white. All subjects in the South American study were categorized as Latin American. We adjusted for 
study center in all logistic regression models as a proxy variable for race/ethnicity because each center had an expected predominant ethnic group distribution. 
 ||  Information on education level was collected in each study as highest degree earned (Houston, Puerto Rico, Tampa, North Carolina, and Seattle studies), years of 
education (Iowa, Los Angeles, Italy Multicenter, Aviano, Milan, Switzerland, International Multicenter, and South America studies), or age at last formal education 
(Central Europe study). The French study did not collect information on education level. In the analysis, for subjects with missing information on education level, 
we applied multiple imputation (n = 5 imputations), by using a logistic regression model, with age, sex, race/ethnicity, case – control status, and study as 
predictors for education level, within geographic region. 
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and South America (OR = 3.58, 95% CI = 1.24 to 10.30) than for 
studies in India and Sudan (OR = 1.17, 95% CI = 0.78 to 1.76) and 
North America (OR = 1.20, 95% CI = 0.86 to 1.67). Dose – response 
trends for the frequency, duration, and pack-years of cigarette 
smoking were apparent for studies in Europe, South America, and 
North America, but not for studies in India and Sudan (data not 
shown). 
 Alcohol Drinking and Head and Neck Cancer Risk Among 
Never Users of Tobacco 
 Among never users of tobacco, there was no association between 
ever drinking alcohol and the risk of head and neck cancer (OR = 
1.18, 95% CI = 0.93 to 1.50;  Table 3 ). Heterogeneity among the 
study estimates was indicated for ever alcohol drinking ( P for het-
erogeneity<.001), for categories of frequency ( P for heterogeneity = 
.006), and for duration ( P for heterogeneity<.001) of alcohol con-
sumption. In an influence analysis, individual exclusions of the Italy 
Multicenter study (OR = 1.23, 95% CI = 0.99 to 1.53), the Seattle 
study (OR = 1.24, 95% CI = 0.99 to 1.54), or the Iowa study (OR = 
1.23, 95% CI = 1.01 to 1.51) resulted in borderline statistically 
significant associations for ever drinking. No dose – response rela-
tionship was apparent for the duration of alcohol use and the risk of 
head and neck cancer among never users of tobacco. However, 
consuming an increasing number of drinks per day was associated 
with a greater risk of head and neck cancer among never users of 
tobacco ( P trend = .001;  Table 5 ). More specifically, never users of 
tobacco who consumed three or more alcoholic drinks per day 
had approximately twice the risk of head and neck cancer as never 
drinkers (OR = 2.04, 95% CI = 1.29 to 3.21;  Fig. 1 ). The influence 
analysis confirmed that the increased risk of head and neck cancer 
associated with consuming three or more drinks per day was not 
due to any one study. The odds ratios for alcohol drinking did not 
change substantially when the analysis was restricted to relatively 
large studies (i.e., those with more than 500 case subjects in the 
original study). Adjustment for family history of cancer or for pas-
sive smoking also did not change the odds ratio for alcohol drinking 
substantially (data not shown). 
 An analysis of never users of tobacco stratiﬁ ed by cancer subsite 
revealed a dose – response relationship, with monotonic increasing 
risks for the frequency of alcohol consumption on the risks of pha-
ryngeal and laryngeal cancers ( Table 6 ). For pharyngeal cancer, 
increased risks were observed for subjects who drank one to two 
drinks per day (OR = 1.66, 95% CI = 1.18 to 2.34), whereas for 
laryngeal cancer, an increased risk was observed for drinking 
ﬁ ve or more drinks per day (OR = 2.98, 95% CI = 1.72 to 5.17). 
Monotonic increasing risks were not observed for the duration of 
alcohol consumption, even though the  P trend was statistically sig-
niﬁ cant for all cancer subsites. Differences in risk associated with 
alcohol consumption were not observed when the analyses of never 
users of tobacco were further stratiﬁ ed by age, sex, race/e thnicity, 
education level, study region, or source of control subjects. 
 Attributable Fractions 
 Approximately 24% (95% CI = 16% to 31%) of the cases of head 
and neck cancer among the never drinkers were attributable to ever 
cigarette smoking, assuming a causal relationship. Among the never 
users of tobacco, 7% (95% CI =  − 4% to 16%) of the cases of head 
and neck cancer were attributable to alcohol drinking, assuming a 
causal relationship. 
 Discussion 
 The results of this pooled analysis confirm previous findings 
that cigarette smoking is a strong risk factor for head and neck 
cancer independent of alcohol drinking. Seven of the 15 studies we 
included showed a statistically significant association between ever 
having smoked cigarettes and the risk of head and neck cancer in 
never drinkers, including dose – response relationships for smoking 
frequency and duration. Based on an earlier review of epidemio-
logic studies reviewed in the IARC monograph (21), the magnitude 
of average relative risks for tobacco smoking were 4.0 – 5.0 for oral 
cavity cancers, 4.0 – 5.0 for oro- and hypopharyngeal cancers, and 
 Table 3 .  Cigarette smoking among never drinkers and the risk of 
head and neck cancer * 
 Never drinkers 
 Smoking variable
Case 
subjects
Control 
subjects OR † (95% CI) 
 Cigarette smoking  
  Never 854 2577 1.00 (referent) 
  Ever 720 1425 2.13 (1.52 to 2.98) 
  Missing 24 49  
 P for heterogeneity ‡ <.001 
 Frequency, cigarettes/day  
  Never smokers 854 2577 1.00 (referent) 
  1 – 10 202 481 1.82 (1.28 to 2.59) 
  11 – 20 281 601 2.36 (1.60 to 3.47) 
  21 – 30 119 154 3.58 (2.09 to 6.16) 
  31 – 40 72 102 4.46 (2.54 to 7.83) 
  >40 37 60 2.69 (1.21 to 5.98) 
  Missing 33 76  
 P trend <.001 
 P for heterogeneity ‡ <.001 
 Duration, y  
  Never smokers 854 2577 1.00 (referent) 
  1 – 10 63 200 1.45 (1.04 to 2.03) 
  11 – 20 59 269 1.10 (0.75 to 1.61) 
  21 – 30 133 362 1.79 (1.20 to 2.67) 
  31 – 40 202 324 3.61 (2.26 to 5.75) 
  >40 255 249 4.83 (3.18 to 7.33) 
  Missing 32 70  
 P trend <.001 
 P for heterogeneity ‡ <.001 
 Cumulative smoking, py  
  Never smokers 854 2577 1.00 (referent) 
  1 – 10 139 407 1.58 (1.13 to 2.22) 
  11 – 20 108 291 1.85 (1.08 to 3.16) 
  21 – 30 109 219 2.75 (1.71 to 4.43) 
  31 – 40 91 152 4.06 (2.33 to 7.09) 
  41 – 50 70 101 3.46 (1.97 to 6.09) 
  >50 193 219 5.40 (3.06 to 9.53) 
  Missing 34 85  
 P trend <.001 
 P for heterogeneity ‡ <.001 
 *  OR = odds ratio; CI = confidence interval; py = pack-years; dy = drink-years. 
 †  Random-effects model used. Study-specific odds ratios were adjusted for 
age, sex, race/ethnicity, education level, study center, years of cigar smoking 
(continuous), and years of pipe smoking (continuous). 
 ‡  Two-sided test for heterogeneity among studies. 
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 Fig. 1 .  The risk of head and neck cancer as -
sociated with cigarette smoking in never 
drinkers of alcohol ( left ) and with alcohol 
drinking in never users of tobacco ( right ), 
overall and by study, using International 
Head and Neck Cancer Epidemiology con-
sortium pooled data version 1.0. Odds ratios 
(ORs) for ever versus never cigarette smok-
ing in never drinkers were adjusted for age, 
sex, race/ethnicity, education level, study 
center, years of cigar smoking, and years of 
pipe smoking. Odds ratios for drinking three 
or more alcoholic drinks per day versus 
never drinking in never users of tobacco 
were adjusted for age, sex, race/ethnicity, 
education level, and study center. Study-
speciﬁ c estimates for the Paris, France, study 
were not available because none of the sub-
jects were never users of tobacco and, 
among the never drinkers, none of the con-
trol subjects were never cigarette smokers. 
 Squares = study-speciﬁ c odds ratios;  size of 
the square = the weight given to this study 
(inverse of the variance of the log odds ratio) 
when estimating the summary odds ratio;  horizontal lines = study-speciﬁ c conﬁ dence intervals (CIs);  diamond = summary estimate combining the 
study-speciﬁ c estimates with a random-effects model;  solid vertical line = odds ratio of 1;  dashed vertical line = summary odds ratio. 
 Table 4 .  Cigarette smoking and the risk of head and neck cancer by subsite among never drinkers * 
 
Oral cavity † (717 case 
subjects/4051 control 
subjects)
Oropharynx/
hypopharynx † , ‡ 
(380 case subjects/3989 
control subjects)
Oral cavity/pharynx 
NOS § (174 case subjects/
3554 control subjects)
Larynx † , || (286 case 
subjects/3045 control 
subjects) 
 Variable
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI)
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI)
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI)
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI) 
 Cigarette smoking  
  Never 505/2577 1.00 (referent) 168/2530 1.00 (referent) 115/2268 1.00 (referent) 41/1822 1.00 (referent) 
  Ever 206/1425 1.35 (0.90 to 2.01) 206/1411 2.02 (1.34 to 3.05) 57/1240 1.07 (0.50 to 2.28) 235/1175 6.84 (4.25 to 11.01) 
  Missing 6/49 6/48 2/46 10/48  
 P for heterogeneity ¶ .019 <.001 .012 <.001 
 Frequency, 
  cigarettes/day  
  Never smokers 505/2577 1.00 (referent) 1.00 (referent) 115/2268 1.00 (referent) 41/1822 1.00 (referent) 
  1 – 10 67/481 1.38 (0.80 to 2.38) 168/2530 2.55 (1.59 to 4.10) 21/424 1.55 (0.86 to 2.79) 42/365 5.72 (3.41 to 9.60) 
  11 – 20 82/601 1.43 (0.85 to 2.38) 67/473 2.15 (1.38 to 3.34) 17/500 1.08 (0.39 to 2.99) 101/530 8.36 (5.18 to 13.51) 
  21 – 30 31/154 1.61 (0.31 to 8.47) 75/596 3.86 (1.80 to 8.25) 11/148 2.68 (1.25 to 5.78) 44/116 14.38 (8.47 to 24.43) 
  31 – 40 15/102 2.92 (0.91 to 9.44) 31/154 4.82 (2.42 to 9.60) 4/94 5.46 (0.92 to 33.47) 32/91 18.38 (7.14 to 47.31) 
  >40 6/60 1.40 (0.30 to 6.61) 18/101 3.10 (1.43 to 6.69) 4/59 6.00 (1.48 to 24.29) 14/47 11.02 (4.92 to 24.72) 
  Missing 11/76 13/60 2/61 12/74  
 P trend .044 8/75 <.001 .001 <.001 
 P for heterogeneity ¶ .051 <.001 .003 <.001 
 Duration, y  
  Never smokers 505/2577 1.00 (referent) 168/2530 1.00 (referent) 115/2268 1.00 (referent) 41/1822 1.00 (referent) 
  1 – 10 27/200 1.37 (0.84 to 2.23) 19/199 1.69 (1.00 to 2.88) 5/192 1.71 (0.62 to 4.74) 8/171 4.33 (1.13 to 16.62) 
  11 – 20 22/269 1.16 (0.64 to 2.10) 17/267 1.18 (0.61 to 2.28) 7/228 2.35 (0.69 to 7.96) 12/233 3.48 (1.61 to 7.50) 
  21 – 30 45/362 1.32 (0.92 to 1.91) 32/357 1.47 (0.94 to 2.31) 12/295 2.14 (0.94 to 4.86) 42/298 5.75 (2.94 to 11.23) 
  31 – 40 46/324 2.28 (1.19 to 4.37) 65/320 3.74 (2.61 to 5.38) 13/278 2.07 (0.88 to 4.84) 73/271 9.30 (5.40 to 16.02) 
  >40 62/249 3.23 (1.54 to 6.77) 71/247 4.84 (2.22 to 10.54) 20/226 2.56 (1.29 to 5.07) 98/182 16.32 (9.58 to 27.79) 
  Missing 10/70 8/69 2/67 12/68  
 P trend .001 <.001 <.001 <.001 
 P for heterogeneity ¶ .023 <.001 .030 <.001 
 *  Random-effects model used for all odds ratios. NOS = not otherwise specified; OR = odds ratio; CI = confidence interval. 
 †  Adjusted for age, sex, race/ethnicity, education level, study center, years of cigar smoking (continuous), and years of pipe smoking (continuous). 
 ‡  Does not include the Central Europe study. 
 §  Does not include the Switzerland and Central Europe studies. 
 ||  Does not include the International Multicenter, Seattle, and Puerto Rico studies. 
 ¶  Two-sided test for heterogeneity. 
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10.0 for laryngeal cancers (21,37). We did not expect our estimates 
among never drinkers to be the same as the estimates by Vineis 
et al. (37), whose analyses were not restricted to never drinkers. Of 
interest, however, is our finding that the risk was stronger for laryn-
geal cancer than for oral cavity and pharyngeal cancers, which is 
consistent with the Vineis estimates. For example, in the review by 
Vineis et al. (37), the average relative risk of laryngeal cancer was 
10-fold higher for ever cigarette users versus never users across 25 
case – control studies and five cohort studies, which was similar to 
the sevenfold increase in risk we observed among never drinkers 
in our pooled analysis of 15 case – control studies. We estimated 
increased risks of 1.4-fold for oral cavity cancers and twofold for 
oro- and pharyngeal cancers, for ever versus never smokers among 
never drinkers of alcohol. The difference in risk by subsite observed 
in our study was independent of associations with the use of cigars, 
pipes, chewing tobacco, or snuff; exclusion of subjects who had 
these other tobacco habits from the analysis did not change the dif-
ferences observed in risk by subsite. These results suggest that the 
larynx is the organ within the head and neck that is most susceptible 
to the effects of cigarette smoking. However, the mechanism for 
this increased susceptibility is unclear. 
 We also detected heterogeneity by geographic region for the 
association between cigarette smoking and the risk of head and neck 
cancer in never drinkers: a higher risk was observed for studies in 
Europe and South America than for studies in North America. This 
difference may reﬂ ect the fact that cigarettes from different coun-
tries and regions differ with respect to their content of nitrosamines, 
polycyclic aromatic hydrocarbons, and other tobacco carcinogens 
(38). The content of these compounds in cigarettes is also known to 
change over time (38). Patterns of smoking, such as the depth of 
inhalation, were not captured in most of the included studies and 
may also have varied across and between regions. In addition, socio-
logic differences among societies may have led to different smoking 
and drinking practices; for example, because there were fewer 
smokers who were also never drinkers in the United States than in 
other countries, the precision of our estimates was decreased for 
some studies. Additional sources of heterogeneity for the associa-
tion with cigarette smoking in never drinkers may include the dif-
ferences across study centers in terms of the relative proportions of 
case subjects with cancers at different anatomic subsites. 
 Our results suggest that, in the absence of tobacco use, the 
association between alcohol consumption and the risk of head and 
neck cancer is weak and is apparent only at high doses and only for 
pharyngeal and laryngeal cancers. Dose – response trends for both 
the frequency and duration of alcohol drinking were strongest for 
cancers of the pharynx, which suggests that it is the organ within 
the head and neck that is most sensitive to the carcinogenicity of 
alcoholic beverages. The ﬁ nding of an increased cancer risk only 
at high levels of alcohol intake in never smokers is consistent with 
results from two studies that were not included in this pooled 
dataset, one on oral cavity cancer in the United States (26) and the 
other on head and neck cancers in Brazil (28). There are several 
possible mechanisms for how alcoholic beverages might exert a 
carcinogenic effect in the head and neck, including ethanol acting 
as a solvent for carcinogens, ethanol or its metabolite acetaldehyde 
damaging DNA, and constituents other than ethanol in alcoholic 
beverages acting as carcinogens. 
 Our study has several limitations. First, we applied a global 
value for the percentage of ethanol found in each alcoholic bever-
age type (wine, beer, hard liquors). Although the ethanol content 
of wine and beer is likely to be relatively consistent across coun-
tries and regions in the world (33), there is considerable potential 
for variation in ethanol content among hard liquors that we did not 
take into account in this study. Case subjects were more likely than 
control subjects to drink hard liquors; thus, misclassiﬁ cation of 
alcohol exposures may have been more severe for case subjects 
than for control subjects, which could have biased the results 
away from the null. However, this potential misclassiﬁ cation 
would not affect our estimates for the duration of drinking or for 
ever drinking, for which we observed associations with the risk of 
pharyngeal cancer, because we did not apply a global value for the 
percentage of ethanol for these variables. 
 Table 5 .  Alcohol drinkers among never users of tobacco and the 
risk of head and neck cancer * 
 Never users of tobacco 
 Drinking variable
Case 
subjects
Control 
subjects OR † (95% CI) 
 Alcohol drinking  
  Never 541 2482 1.00 (referent) 
  Ever 523 3290 1.18 (0.93 to 1.50) 
  Missing 8 3  
 P for heterogeneity ‡ <.001 
 Frequency, drinks/day  
  Never drinkers 541 2482 1.00 (referent) 
  <1 164 899 1.04 (0.79 to 1.38) 
  1 – 2 202 1324 1.30 (0.94 to 1.80) 
  3 – 4 59 536 1.82 (1.10 to 2.99) 
  ≥ 5 65 389 2.81 (1.49 to 5.27) 
  Missing 41 145  
 P trend .001 
 P for heterogeneity ‡ <.001 
 Duration, y  
  Never drinkers 541 2482 1.00 (referent) 
  1 – 10 59 211 1.56 (1.11 to 2.19) 
  11 – 20 70 447 1.22 (0.87 to 1.71) 
  21 – 30 121 774 1.27 (0.87 to 1.87) 
  31 – 40 138 919 1.17 (0.84 to 1.62) 
  >40 years 106 813 1.05 (0.65 to 1.68) 
  Missing 37 129  
 P trend .319 
 P for heterogeneity ‡ <.001 
 Cumulative drinking, dy  
  Never drinkers 541 2482 1.00 (referent) 
  1 – 10 147 747 1.07 (0.82 to 1.39) 
  11 – 20 64 339 1.31 (0.86 to 1.98) 
  21 – 30 42 260 1.33 (0.73 to 2.42) 
  31 – 40 33 219 1.31 (0.86 to 2.01) 
  41 – 50 23 190 1.15 (0.70 to 1.90) 
  >50 179 1391 1.87 (1.27 to 2.75) 
  Missing 43 147  
 P trend .003 
 P for heterogeneity ‡ <.001 
 *  OR = odds ratio; CI = confidence interval; py = pack-years; dy = drink-years. 
 †  Random-effects model used. Study-specific odds ratios were adjusted for 
age, sex, race/ethnicity, education level, and study center. 
 ‡  Two-sided test for heterogeneity among studies. 
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 Second, some individuals who had minimal levels of tobacco or 
alcohol use might have been included in the “never user of 
tobacco” and “never drinker” categories in the analysis because of 
the wording on the questionnaires used to establish the “unex-
posed” groups in some of the studies. The studies with the highest 
thresholds for classifying an individual as unexposed were the 
North Carolina study (in which a never drinker was deﬁ ned as an 
individual who consumed three or fewer drinks per month), the 
Iowa study (in which a never cigarette smoker was deﬁ ned as an 
individual who smoked less than one-half pack of cigarettes per 
week for <1 year), and the Tampa or Houston studies (in which a 
never drinker was deﬁ ned as an individual who consumed alcohol 
one or more times per week for one or more years), and the 
International Multicenter study (in which never use of cigars, 
pipes, chewing tobacco, or snuff was deﬁ ned as smoking cigars or 
pipes, chewing, or snufﬁ ng less than daily for <1 year). However, 
the odds ratios for these studies with the highest thresholds were 
not substantially higher than would be expected if inclusion of 
these minimal users had an impact on the associations. 
 Third, although we excluded the possibility of residual con-
founding by tobacco in the assessment of alcohol drinking and by 
alcohol in the assessment of cigarette smoking, we did not adjust 
for other potential confounders that are associated with the risk 
of the head and neck cancer, such as human papillomavirus (HPV) 
infection (19) and diet and nutrition (39,40). However, a recent 
analysis (41) of data from the International Multicenter study 
(which were included in this pooled analysis) did not show an 
inverse association between fruit and vegetable intake and the 
risks of oral cavity or oropharyngeal cancers among never users 
of tobacco or never drinkers of alcohol, which suggests that our 
results are unlikely to be due to confounding by fruit and vegetable 
intakes. Although HPV infection appears to be an important risk 
factor for oral cavity and oropharyngeal cancers for never users of 
tobacco (19), no association between cigarette smoking and HPV 
infection in the general population or source population of never 
users of tobacco has been established (42,43). In addition, accord-
ing to several survey studies (44,45), it seems unlikely that alcohol 
drinking is associated with HPV infection in either the general 
 Table 6 .  Alcohol drinking and the risk of head and neck cancer by subsite among never users of tobacco * 
 
Oral cavity † (383 case 
subjects/5775 control 
subjects)
Oropharynx/
hypopharynx ‡ 
(369 case subjects/5775 
control subjects)
Oral cavity/pharynx 
NOS † , § (155 case 
subjects/4983 control 
subjects)
Larynx † , || (121 case 
subjects/4602 control 
subjects) 
 Variable
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI)
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI)
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI)
No. of case 
subjects/
No. of 
control 
subjects OR (95% CI) 
 Alcohol consumption  
  Never 243/2482 1.00 (referent) 153/2482 1.00 (referent) 80/1982 1.00 (referent) 40/1788 1.00 (referent) 
  Ever 137/3290 1.17 (0.92 to 1.48) 216/3290 1.38 (0.99 to 1.94) 72/2998 1.09 (0.77 to 1.54) 79/2812 1.21 (0.82 to 1.79) 
  Missing 3/3 0/3 3/3 2/2  
 P for heterogeneity ¶ .087 <.001 .141 .193 
 Frequency, drinks/day  
  Never drinker 243/2482 1.00 (referent) 153/2482 1.00 (referent) 80/1982 1.00 (referent) 40/1788 1.00 (referent) 
  <1 44/899 1.14 (0.8 to 1.63) 73/899 1.39 (0.99 to 1.96) 25/834 1.08 (0.67 to 1.75) 15/724 0.92 (0.5 to 1.69) 
  1 – 2 60/1324 1.64 (1.19 to 2.25) 83/1324 1.66 (1.18 to 2.34) 26/1171 1.24 (0.77 to 1.99) 28/1155 1.26 (0.77 to 2.07) 
  3 – 4 10/536 1.11 (0.57 to 2.15) 24/536 2.33 (1.37 to 3.98) 13/495 2.32 (1.24 to 4.34) 11/480 1.24 (0.62 to 2.45) 
  ≥ 5 8/389 1.23 (0.59 to 2.57) 29/389 5.50 (2.26 to 13.36) 4/382 0.77 (0.27 to 2.18) 22/349 2.98 (1.72 to 5.17) 
  Missing 18/145 7/145 7/119 5/106  
 P trend .032 <.001 .891 <.001 
 P for heterogeneity ¶ .913 <.001 .202 .006 
 Duration, y  
  Never drinker 243/2482 1.00 (referent) 153/2482 1.00 (referent) 80/1982 1.00 (referent) 40/1788 1.00 (referent) 
  1 – 10 21/211 2.36 (1.43 to 3.88) 18/211 1.76 (0.99 to 3.14) 13/181 2.59 (1.38 to 4.86) 7/185 2.61 (1.14 to 5.98) 
  11 – 20 17/447 1.09 (0.65 to 1.85) 28/447 1.34 (0.81 to 2.11) 11/394 1.09 (0.56 to 2.11) 9/375 1.63 (0.78 to 3.43) 
  21 – 30 19/774 0.81 (0.49 to 1.33) 63/774 1.95 (1.37 to 2.77) 18/697 1.26 (0.73 to 2.17) 18/673 1.40 (0.79 to 2.48) 
  31 – 40 35/919 1.29 (0.88 to 1.9) 61/919 1.44 (0.78 to 2.66) 14/853 0.86 (0.47 to 1.57) 21/797 1.10 (0.64 to 1.89) 
  >40 32/813 1.15 (0.77 to 1.73) 37/813 1.51 (0.68 to 3.37) 13/773 0.92 (0.49 to 1.71) 21/677 1.00 (0.58 to 1.73) 
  Missing 16/129 9/129 6/103 5/107  
 P trend <.001 .003 .014 <.001 
 P for heterogeneity ¶ .419 <.001 .585 .350 
 *  NOS = not otherwise specified; OR = odds ratio; CI = confidence interval. 
 †  Fixed-effects model, adjusted for age, sex, race/ethnicity, education level, and study center. 
 ‡  Random-effects model. Study-specific odds ratios adjusted for age, sex, race/ethnicity, and education level. 
 §  Does not include the Switzerland and Texas studies. 
 ||  Does not include the International Multicenter, Seattle, and Puerto Rico studies. 
 ¶  Two-sided test for heterogeneity. 
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population or in never users of tobacco. Because the criterion that 
a confounder should be associated with the exposure of interest in 
the source population is not met, we would not expect HPV to be 
a major confounder. 
 Fourth, regional differences in social acceptance of tobacco 
habits and alcohol consumption may have inﬂ uenced how a subject 
responded to questions about these practices in a face-to-face 
interview. Our adjustment for study center may have partially 
addressed this limitation, however. Fifth, recall bias was also a 
potential limitation because in all the studies the subjects knew 
their disease status when they were interviewed. We explored 
whether there were differences in the odds ratios by the source 
of control subjects (hospital based or population based) because 
hospital-based control subjects could have had similar recall bias to 
case subjects depending on the type of disease for which they were 
being treated, but no difference was observed. Thus, we do not 
believe that recall bias could explain our results. 
 The major strength of our pooled analyses was assembly of a 
very large series of never users of tobacco and never drinkers 
among head and neck cancer patients and control subjects, 
which allowed us to examine head and neck cancer risks in detail 
and to explore differences in risks by cancer subsite, geographic 
region, and sex. To our knowledge, the estimates we present are 
the most precise estimates available for the independent associa-
tions of each of the two main risk factors of head and neck can-
cer. In summary, cigarette smoking was conﬁ rmed as a risk 
factor for head and neck cancer among never drinkers, and the 
highest risk was for laryngeal cancer. If the never drinkers had 
not smoked cigarettes, approximately one-quarter of the head 
and neck cancers in this group would have been prevented. 
Alcohol drinking at high frequency was also conﬁ rmed as an 
independent risk factor for head and neck cancers, but the asso-
ciation was limited to cancers of the oropharynx/hypopharynx 
and larynx. 
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